​

Establishment Labs (ESTA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ESTA Stock Forecast

Establishment Labs (ESTA) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $82.50, with a high of $84.00 and a low of $81.00. This represents a 13.71% increase from the last price of $72.55.

$25 $37 $49 $61 $73 $85 High: $84 Avg: $82.5 Low: $81 Last Closed Price: $72.55

ESTA Stock Rating

Establishment Labs stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (85.71%), 2 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 2 12 Strong Sell Sell Hold Buy Strong Buy

ESTA Price Target Upside V Benchmarks

TypeNameUpside
StockEstablishment Labs13.71%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.58%

Price Target Trends

1M3M12M
# Anlaysts144
Avg Price Target$84.00$76.25$76.25
Last Closing Price$72.55$72.55$72.55
Upside/Downside15.78%5.10%5.10%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25261--9
Nov, 25261--9
Oct, 25261--9
Sep, 25261--9
Aug, 25251--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 10, 2025Mike MatsonNeedham$84.00$71.0118.29%15.78%
Nov 14, 2025Sam EiberBTIG$81.00$64.7525.10%11.65%
Nov 06, 2025Needham$70.00$64.917.84%-3.51%
Nov 05, 2025Sam EiberBTIG$70.00$59.5517.55%-3.51%
Aug 22, 2024Joanne WuenschCitigroup$45.00$44.052.16%-37.97%
Jun 06, 2024Anthony PetroneMizuho Securities$70.00$53.8929.89%-3.51%
Apr 01, 2024Anthony PetroneMizuho Securities$65.00$50.9027.70%-10.41%
Dec 28, 2022Stephens$87.00$60.4543.92%19.92%
Apr 22, 2022BTIG$110.00$81.8934.33%51.62%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2025CitigroupNeutralNeutralhold
Dec 10, 2025NeedhamBuyBuyhold
Nov 06, 2025NeedhamBuyBuyhold
Nov 05, 2025BTIGBuyBuyhold
Oct 07, 2025CitigroupNeutralNeutralhold
May 16, 2025BTIGBuyBuyhold
May 14, 2025NeedhamBuyupgrade
Oct 14, 2024Cowen & Co.BuyBuyhold
Oct 01, 2024StephensNeutralNeutralhold
Aug 22, 2024CitigroupUnderperformUnderperformhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.63$-1.72$-3.08$-3.07$-3.03----
Avg Forecast$-1.56$-1.42$-3.21$-3.17$-2.42$-1.81$-1.11$0.75$2.00
High Forecast$-1.50$-1.37$-3.15$-3.14$-2.23$-1.72$-0.72$0.76$2.02
Low Forecast$-1.59$-1.46$-3.24$-3.19$-2.53$-1.95$-1.85$0.73$1.95
Surprise %4.49%21.13%-4.05%-3.15%25.21%----

Revenue Forecast

$50M $150M $250M $350M $450M $550M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$84.68M$126.68M$161.70M$165.15M$166.03M----
Avg Forecast$82.92M$126.30M$160.94M$164.94M$165.97M$206.54M$261.49M$389.80M$519.60M
High Forecast$84.39M$128.55M$162.24M$165.11M$167.16M$207.63M$261.49M$392.60M$523.33M
Low Forecast$80.57M$122.73M$158.44M$164.70M$162.91M$205.46M$261.49M$382.61M$510.02M
Surprise %2.12%0.30%0.47%0.13%0.03%----

Net Income Forecast

$-100M $-60M $-20M $20M $60M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-38.12M$-41.14M$-75.21M$-78.50M$-84.60M----
Avg Forecast$-39.83M$-36.45M$-82.20M$-81.09M$-61.03M$-47.04M$-31.69M$19.06M$51.20M
High Forecast$-38.36M$-35.11M$-80.54M$-80.45M$-57.18M$-44.06M$-18.37M$19.38M$51.68M
Low Forecast$-40.75M$-37.29M$-83.06M$-81.72M$-64.87M$-50.02M$-47.43M$18.74M$49.97M
Surprise %-4.29%12.88%-8.50%-3.19%38.62%----

ESTA Forecast FAQ

Is Establishment Labs stock a buy?

Establishment Labs stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Establishment Labs is a favorable investment for most analysts.

What is Establishment Labs's price target?

Establishment Labs's price target, set by 14 Wall Street analysts, averages $82.5 over the next 12 months. The price target range spans from $81 at the low end to $84 at the high end, suggesting a potential 13.71% change from the previous closing price of $72.55.

How does Establishment Labs stock forecast compare to its benchmarks?

Establishment Labs's stock forecast shows a 13.71% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (19.58%).

What is the breakdown of analyst ratings for Establishment Labs over the past three months?

  • December 2025: 22.22% Strong Buy, 66.67% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 22.22% Strong Buy, 66.67% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 22.22% Strong Buy, 66.67% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.

What is Establishment Labs’s EPS forecast?

Establishment Labs's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.81, marking a -40.26% decrease from the reported $-3.03 in 2024. Estimates for the following years are $-1.11 in 2026, $0.75 in 2027, and $2 in 2028.

What is Establishment Labs’s revenue forecast?

Establishment Labs's average annual revenue forecast for its fiscal year ending in December 2025 is $206.54M, reflecting a 24.41% increase from the reported $166.02M in 2024. The forecast for 2026 is $261.49M, followed by $389.8M for 2027, and $519.6M for 2028.

What is Establishment Labs’s net income forecast?

Establishment Labs's net income forecast for the fiscal year ending in December 2025 stands at $-47.042M, representing a -44.39% decrease from the reported $-84.596M in 2024. Projections indicate $-31.688M in 2026, $19.06M in 2027, and $51.2M in 2028.